Progyny Short Interest Drops 22.4%

Shares of the fertility benefits management company see large decrease in short positions

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Progyny, Inc. (NASDAQ:PGNY), a New York-based fertility benefits management company, saw a significant 22.4% decrease in short interest in January. As of January 30th, there were 2,847,787 shares shorted, down from 3,669,670 shares on January 15th. The drop in short positions comes as the company's stock has seen increased trading volume and a rise in its share price in recent months.

Why it matters

The decrease in short interest could signal growing investor confidence in Progyny's business model and future prospects. As a provider of comprehensive family-building programs for employers and health plans, the company has seen increased demand for its services amid rising infertility rates and a greater focus on employee wellness benefits.

The details

Progyny's short interest ratio, which measures the number of shares shorted relative to the company's average daily trading volume, currently stands at 2.0 days. This indicates that it would take short sellers approximately 2 days to cover their positions based on the stock's typical daily volume. The decrease in short interest comes as Progyny's share price has risen from a 52-week low of $17.98 to a high of $28.75 over the past year.

  • As of January 30th, 2026, Progyny had 2,847,787 shares shorted.
  • On January 15th, 2026, Progyny had 3,669,670 shares shorted.

The players

Progyny, Inc.

A New York-based fertility benefits management company that partners with employers and health plans to design and administer comprehensive family-building programs.

Got photos? Submit your photos here. ›

The takeaway

The drop in short interest for Progyny suggests growing investor confidence in the company's ability to capitalize on the increasing demand for fertility benefits and family-building services. As more employers prioritize employee wellness, Progyny's unique approach to managing these complex benefits could continue to drive growth and attract investor interest.